Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use - RCT
1 other identifier
interventional
50
1 country
1
Brief Summary
The overall goal of this pilot study is to develop and preliminarily evaluate an LPA intervention designed to reduce cannabis use during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Jan 2024
Typical duration for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2024
CompletedFirst Submitted
Initial submission to the registry
January 26, 2024
CompletedFirst Posted
Study publicly available on registry
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedFebruary 23, 2026
February 1, 2026
2.2 years
January 26, 2024
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (11)
Timeline Follow-back (TLFB)
Interviewer-administered assessment of use of cannabis, alcohol, tobacco, and other drugs
Baseline to 12-week endpoint
Steps/day
objectively-measured
Baseline to 12-week endpoint
Activity Minutes/Day
objectively-measured
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 1
Self-reported cannabis use questionnaire -factor 1: daily sessions
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 2
Self-reported cannabis use questionnaire - factor 2: frequency
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 3
Self-reported cannabis use questionnaire - factor 3: age of onset
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 4
Self-reported cannabis use questionnaire - factor 4: Marijuana quantity
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 5
Self-reported cannabis use questionnaire - factor 5: Concentrate quantity
Baseline to 12-week endpoint
The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 6
Self-reported cannabis use questionnaire - factor 6: Edibles quantity
Baseline to 12-week endpoint
Urine Toxicology Screen
Objective screening for use of cannabis via measurement of THC in urine samples
Baseline to 12-week endpoint
International Physical Activity Questionnaire
self-report measure of physical activity including minutes/week spent walking, engaging in moderate physical activity, and engaging in vigorous physical activity
Baseline to 12-week endpoint
Secondary Outcomes (4)
Brief COPE
Baseline to 12-week endpoint
Marijuana Self-Efficacy Questionnaire
Baseline to 12-week endpoint
Edinburgh Postnatal Depression Screen
Baseline to 12-week endpoint
Generalized Anxiety Disorder -7
Baseline to 12-week endpoint
Study Arms (2)
LPA and Fitbit
EXPERIMENTALThe 12-week LPA+Fitbit intervention consists of 3 components: 1. In-Person LPA+Fitbit Orientation 2. Telephone PA counseling sessions. 3. Fitbit activity tracker.
Only Fitbit
ACTIVE COMPARATORThe Fitbit Only condition will include 3 components: 1. In-person Fitbit Orientation. 2. Fitbit Activity Tracker. 3. Brief Telephone Check-ins.
Interventions
1. In-Person LPA+Fitbit Orientation. During an initial, orientation (45 minutes), a study interventionist will provide information regarding the acute and long-term psychological and physical benefits of increasing PA, including prenatally. 2. Telephone PA counseling sessions. A study interventionist will call participants at weeks 2, 4, 6, 8, and 10 of the intervention for a 20-min telephone session. 3. Fitbit activity tracker. With participant permission, a Fitbit account (on Fitbit.com) and study-generated password will be created. In doing so, investigators will have access to the participant activity data throughout the intervention. The Fitbit web-based and mobile apps facilitate goal-setting by allowing participants to easily set goals and change these goals at any point. We will customize each participant account to display daily steps and very active minutes, though they will be encouraged to adjust the display according to their preferences.
1. In-person Fitbit Orientation. Participants will be given information on the public health guidelines for PA during pregnancy, and as well as how to determine if their PA is moderate-intensity. In addition, interventionists will orient participants to the proper use of the Fitbit tracker and offer tips for self-monitoring step counts with the tracker and on the app. 2. Fitbit Activity Tracker. Participants will be given the same Fitbit as in the LPA condition. Participants will not be given any specific step count goals to achieve during the 12-week intervention. 3. Brief Telephone Check-ins. As with the LPA+Fitbit participants, those in the Fitbit Only condition will receive phone calls on weeks 2, 4, 6, 8, 10. These calls will last 5 minutes and be focused entirely on answering any problems related to the Fitbit such as syncing issues, charging the battery, and any other technical problems that may arise. No physical activity counseling will be delivered on these calls.
Eligibility Criteria
You may qualify if:
- women 18+ years of age
- weeks gestation with a healthy singleton pregnancy
- medically-cleared by their prenatal provider for moderate intensity physical activity
- self-report of cannabis use at least once/week in the 3 months prior to the current pregnancy and desire to not engage in prenatal CU
- current psychological distress as defined by Edinburgh Postnatal Depression Scale score \>7 and/or Generalized Anxiety Disorder 7 score \>5)
- English-speaking
- owns a smartphone to enable use of the Fitbit app
- current physical activity level does not meet public health recommendations (less than 150 minutes/week moderate intensity physical activity for the past 3 months)
- expresses interest in reducing or discontinuing CU
You may not qualify if:
- current DSM-5 diagnosis of moderate/severe substance use disorder other than cannabis use disorder or nicotine use disorder
- use of illicit substances in the last 3 months (other than cannabis)
- acute psychotic symptoms
- current or recent suicidality or homicidality
- current anorexia or bulimia
- current cognitive impairment
- physical or medical problems that would not allow safe participation in moderate intensity physical activity
- has plan to relocate away from the geographic area during the study intervention or assessment period
- recently started a new form of mental health or substance use treatment within the past 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Butler Hospitallead
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Battle, PhD
Butler Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2024
First Posted
February 2, 2024
Study Start
January 22, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share